Novoprotein’s Role in the Fight Against Cancer

A Family of Diseases:

Each year 12.7 million people discover they have cancer and 7.6 million people die from the disease, but even despite the numbers and the commonality, cancer is still not very well understood by the public, and still remains a difficult topic for scientific and medical professionals.

A common misconception by the public is that ‘cancer’ is a single, monolithic entity; that every cancer is the same. With such thinking, one would expect there be a single, one-size-fits-all cure that can be obtained. However, life is never so simple. Cancers are, in fact, a large family of diseases. These diseases affect cell growth and can spread quickly throughout the body. Not only are cell growth & division advanced by cancers, but lowers or effectively eliminates apoptosis. Apoptosis, also known as “programmed cell death”, is a normal way for your body to get rid of older or excessive cells. Average humans loose tens of billions of cells a day, which allows for maintaining balance in the body. However, the combination of rapid cell growth, and lowered cell deletion results in characteristic tumors, yet can also lead to many other (often misleading) symptoms.

Scientists have long since been working on researching cancer, and while there are now vasts quantities of knowledge on the subject due to decades of research, there is an untold amount we still do not know. The fight against cancer continues, and the first steps are taken in laboratory settings.

Laboratory Front Lines:

So many advancements are happening in the medical field, it is easy to be overwhelmed by it all. Yet understanding the methods scientists use, and the steps involved, helps structure these advancements, and frame them in an understandable concept.

Another thing to remember before continuing, especially in a sensationalist society, is to take experiments (even those published) with a grain of salt. The scientific community has a system of checks and balances; although one person may find correlations in data, there is a process the experiments and theories must go through before they are accepted as fact. That being said, these initial experiments and theories are the first steps in solving the problems they face, and if they can be recreated by others and can be verified, they are invaluable beginnings to new advancements.

That being said, let us look at some of the most recent advancements in cancer research, and those of which involved Novoprotein’s products.

Publications:

Science China Life Sciences is a peer-reviewed open access cademic journal co-sponsored by the Chinese Academy of Sciences and the National Natural Science Foundation of China. With 168 issues to date (06/08/2016) since 1997, over two thousand articles have been published. In the April 2016 edition of Life Sciences, dealt with tumors and CAR-T therapy to show that “MUC1 positive metastatic seminal vesicle cancer can be effectively eradicated”.

Food & Function provides a unique venue for physicists, chemists, biochemists, nutritionists and other food scientists to publish work at the interface of the chemistry, physics and biology of food. The February 2016 edition of Food & Function dealt with anticancer activities that stem from Trichosanthes kirilowii fruitThis has an effect on apoptosis.

Biochemical and Biophysical Research Communications, shortened as BBRC, is an international journal devoted to the very rapid dissemination of timely and significant experimental results in diverse fields of biological research. In May 2016, BBRC published anticancer effects that targeted specific signaling.

Scientific Reports, which is under The Nature journals, has thousands of peer-editors, and is a central resource for information about open access and open research at Nature Publishing Group. The April 2016 publication of Scientific Reports involved  a well-known tumor-suppressive miRNA that is frequently downregulated in multiple cancers.

Spandidos Publications was founded in 1992 and has developed into a leading publishing group in the biomedical sciences field. SP currently publishes eight journals: International Journal of Molecular Medicine, International Journal of Oncology, Molecular Medicine Reports, Oncology Reports, Experimental and Therapeutic Medicine, Oncology Letters, Biomedical Reports and Molecular and Clinical Oncology. The November 2015 Molecular Medicine Reports journal also dealt with downregulated expressions.

More and more is published every month, and there are plenty of older articles as well, but Novoprotein is proud to be a part of each and every discovery that we can. We delight in the chance to provide researchers with the tools needed to reach these advancements, and look forward to continuing our service to the scientific community.